Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A.
Kaley TJ, et al. Among authors: karimi s.
Neuro Oncol. 2015 Jan;17(1):116-21. doi: 10.1093/neuonc/nou148. Epub 2014 Aug 6.
Neuro Oncol. 2015.
PMID: 25100872
Free PMC article.
Clinical Trial.